The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication

Abstract The lack of coronavirus-specific antiviral drugs has instigated multiple drug repurposing studies to redirect previously approved medicines for the treatment of SARS-CoV-2, the coronavirus behind the ongoing COVID-19 pandemic. A recent, large-scale, retrospective clinical study showed that...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Madeline Loffredo, Hector Lucero, Da-Yuan Chen, Aoife O’Connell, Simon Bergqvist, Ahmad Munawar, Asanga Bandara, Steff De Graef, Stephen D. Weeks, Florian Douam, Mohsan Saeed, Ali H. Munawar
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/e07d8710ce004328ab2ec83a48a74f35
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!